Application 218650
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS USA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | RIFAXIMIN | RIFAXIMIN | TABLET | 200MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XIFAXAN | RIFAXIMIN | Cardinal Health 107, LLC | 7afafa63-3236-4212-9589-045db6b01c0b | 2025-08-27 | Warnings, Adverse reactions | RIFAXIMIN |
| XIFAXAN | RIFAXIMIN | Salix Pharmaceuticals, Inc. | c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | 2025-06-25 | Warnings, Adverse reactions | RIFAXIMIN |
| XIFAXAN | RIFAXIMIN | A-S Medication Solutions | f73acb74-e930-4414-81e9-d2a01db36e30 | 2023-02-04 | Warnings, Adverse reactions | RIFAXIMIN |